A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
Abstract Purpose To report results from our phase I dose-escalation study of stereotactic body radiotherapy (SBRT) using 4 fractions for patients with localized prostate cancer. Materials & methods Fraction sizes of 8 Gy, 8.5 Gy, and 9 Gy were defined as levels 1, 2, and 3. The prescribed dose w...
Main Authors: | Takuro Kainuma, Shogo Kawakami, Hideyasu Tsumura, Takefumi Satoh, Ken-ichi Tabata, Masatsugu Iwamura, Kazushige Hayakawa, Hiromichi Ishiyama |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-019-1369-y |
Similar Items
-
Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients
by: Kyohei Fujii, et al.
Published: (2023-05-01) -
Robotic Stereotactic Radiotherapy for Intracranial Meningiomas—An Opportunity for Radiation Dose De-Escalation
by: Hanna Grzbiela, et al.
Published: (2023-11-01) -
Comparison of prostate contours between conventional stepping transverse imaging and Twister-based sagittal imaging in permanent interstitial prostate brachytherapy
by: Shogo Kawakami, et al.
Published: (2017-08-01) -
Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity
by: Christy Goldsmith, et al.
Published: (2018-10-01) -
Escalated Maximum Dose in the Planning Target Volume Improves Local Control in Stereotactic Body Radiation Therapy for T1-2 Lung Cancer
by: Takaya Inagaki, et al.
Published: (2022-02-01)